1-2 of 2
Yuta Yamamoto
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Generation, Transcriptomic States, and Clinical Relevance of CX3CR1+ CD8 T Cells in Melanoma

Hirohito Ishigaki, Takayoshi Yamauchi, Mark D. Long, Toshifumi Hoki, Yuta Yamamoto, Takaaki Oba, Fumito Ito
Journal: Cancer Research Communications
Cancer Research Communications (2024) 4 (7): 1802–1814.
https://doi.org/10.1158/2767-9764.CRC-24-0199
Published: 24 July 2024
View article titled, Generation, Transcriptomic States, and Clinical Relevance of CX3CR1<sup>+</sup> CD8 T Cells in Melanoma
Open the PDF for Generation, Transcriptomic States, and Clinical Relevance of CX3CR1<sup>+</sup> CD8 T Cells in Melanoma in another window
Includes: Supplementary data
Journal Articles

Combination of a New Oral Demethylating Agent, OR2100, and Venetoclax for Treatment of Acute Myeloid Leukemia

Kazuharu Kamachi, Hiroshi Ureshino, Tatsuro Watanabe, Nao Yoshida-Sakai, Yuki Fukuda-Kurahashi, Kazunori Kawasoe, Toshimi Hoshiko, Yuta Yamamoto, Yuki Kurahashi, Shinya Kimura
Journal: Cancer Research Communications
Cancer Research Communications (2023) 3 (2): 297–308.
https://doi.org/10.1158/2767-9764.CRC-22-0259
Published: 21 February 2023
View article titled, Combination of a New Oral Demethylating Agent, OR2100, and Venetoclax for Treatment of Acute Myeloid Leukemia
Open the PDF for Combination of a New Oral Demethylating Agent, OR2100, and Venetoclax for Treatment of Acute Myeloid Leukemia in another window
Includes: Supplementary data